Search

everythinglearnresearchcommunity

for

Search:↓

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss in Discoid Lupus.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Potential therapeutic targets for scarring hair loss are identified.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The vitreous membrane in hair follicles changes shape during the hair cycle and may affect hair growth and nutrient exchange.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Atopic dermatitis affects the appearance of skin reactions, making certain features more common and improving diagnostic accuracy with dermoscopy.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Immune activities and specific genes are important in male pattern baldness.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Researchers found four genes that could help diagnose severe alopecia areata early.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.